Mako should benefit from the robotic surgical approach in the Orthopedic field. Strategies Three healthcare stocks I’m buying: Mako, ResMed and Centene
Investing and even non-investing voters are being gradually and systematically anesthetized to the risks and consequences of Fed and Treasury policies. Strategies Don’t be the frog in boiling water
Macro-economic events currently drive micro-economic investment portfolios. Today the focus is on Europe. Tomorrow it may be China, Japan or the U.S. Strategies Signs of progress in January
Our economy and markets should move ahead slowly, but in an upward direction. Strategies These sectors should outperform over 2012
Can they monetize their business in a more significant way without turning off users? Strategies Two big risks in the Facebook IPO
Emerging markets were supposed to untether themselves from the debt-burdened West and find their own way in the world. It didn't work out that way. Strategies Decoupling? Not in this lifetime.
Will the Year of the Dragon be a flying and fire-breathing beast for the markets? Strategies The macro trends that matter this year
Underlying investor mood is not overly bullish yet, which points to potentially higher prices ahead. Strategies Silver could gain significantly in coming months
We expect there will be a correction at some point, but my guess is that buying that correction will be the right move as opposed to selling it. Strategies This rally appears to have real legs
Management at Gigamedia always keeps it interesting. Strategies My six Concentrated GARP stocks could have a strong 2012
Here's an example of why we focus almost exclusively on a company’s business model and market opportunity. Strategies IBM continues to confound and amaze
The music service appears more difficult for another startup to replicate. Strategies Pandora’s more attractive than other recent web IPOs